Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Description of Business and Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Stockholders' Equity (Tables)

v3.3.1.900

Stockholders' Equity (Tables)

12 Months Ended

Nov. 30, 2015

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at November 30, 2015 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price

$0.42 to $1.00		0		0.00	$	0.00		0	$	0.00
$1.01 to $2.00		465,930		5.48	$	1.72		465,930	$	1.72
$2.01 to $3.00		480,500		4.48	$	2.56		480,500	$	2.56
$3.01 to $4.00		22,500		6.61	$	3.08		7,497	$	3.08

		968,930		5.01	$	2.17		953,927	$	2.16

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of November 30, 2015, and changes during the fiscal year then ended, is presented below:


	Options			Weighted Average Grant-Date Fair Value

Non-vested at November 30, 2014		27,083		$	1.64

Granted		22,500			1.90
Vested		(34,580	)		1.70
Forfeited		—			—

Non-vested at November 30, 2015		15,003		$	1.90

Service-Based Vesting Condition Options [Member]

Fair Value of Options Granted

Variables used to determine the fair value of the options granted for the years ended November 30, 2015 and November 30, 2014 are as follows:


	2015			2014
Weighted average values:
Expected dividends		0	%		0	%
Expected volatility		75.50	%		84.00	%
Risk free interest rate		1.57	%		1.69	%
Expected life		5.0 years			5.0 years

Stock Option Activity for Options

Stock option activity for options with only service-based vesting conditions for the year ended November 30, 2015, was as follows:


	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2014		997,266		$	2.14		5.84	$	661,466

Granted		22,500			3.08				4,950
Exercised		(35,000	)		2.00				39,325
Expired/forfeited		(15,836	)		2.08				19,370


Outstanding at November 30, 2015		968,930		$	2.17		5.01	$	1,095,525

Exercisable at November 30, 2015		953,927		$	2.16		4.99	$	1,092,224

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=ccel_ServiceBasedVestingConditionOptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: